comparemela.com

Page 13 - நீரோடை பார்மா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sun Pharmaceutical, Dr Reddy s Labs, JB Pharmaceuticals, Torrent Pharma and Piramal Pharma eye Oaknet Healthcare

Synopsis Another mid-sized pharma firm, La Renon, backed by Sequoia Capital and A91 Partners is also keen on buying out Oaknet. Binding bids will be submitted by this month and the deal is likely to be signed by May 2021, sources said. A clutch of Indian pharmaceutical majors such as Sun Pharmaceutical, Dr Reddy s Labs (DRL), KKR-owned JB Chemicals & Pharmaceuticals, Torrent Pharma and Piramal Pharma have shown interest in acquiring Oaknet Healthcare, the Mumbai-based drug formulation manufacturer owned by private equity fund Samara Capital. Investment bank Rothschild is advising the fund to find a potential buyer for the business at a valuation of $100 million (about Rs 700 crore), said multiple people aware of the development.

market outlook: Ahead of Market: 12 things that will decide stock action on Friday

market outlook: Ahead of Market: 12 things that will decide stock action on Friday
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

China, Russia & North Korea hackers target AIIMS, SII, Patanjali for Covid data — report

China, Russia & North Korea hackers target AIIMS, SII, Patanjali for Covid data — report Report by cyber intelligence firm Cyfirma says threats to global healthcare firms were noticed in February, hackers targeted those investing in medical research, clinical trials, vaccine production. Himani Chandna 2 March, 2021 8:00 am IST A+ New Delhi: A group of Chinese, Russian and North Korean hackers have targeted crucial information of India’s top drug and vaccine makers including Serum Institute of India (SII), Bharat Biotech, Zydus Cadila and AIIMS, cyber intelligence firm Cyfirma has found. Bharat Biotech and SII have developed vaccines against Covid-19 in India, which were approved for emergency use authorisation in the country in January, and Zydus Cadila is involved in the last stage trial of its Covid vaccine. The All India Institute of Medical Sciences (AIIMS) is the country’s apex public hospital and research institute.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.